05-27-2008: DxS has announced plans to expand its manufacturing facilities, and to significantly increase the number of staff. In addition, the Company has also been awarded the ISO 13485:2003 quality certification for the "design, development and manufacture of molecular diagnostic products for human genetic analysis".
DxS will take on more specialised manufacturing space at its current site in Manchester, and intends to have doubled in size over the coming months. The expansion of DxS' manufacturing capabilities will also see an increase in staff, with further appointments expected during 2008 as these new facilities and other departments are expanded.
The increase in demand follows the recent announcement that Amgen selected the DxS TheraScreen® K-RAS assay as the preferred method of assessing a patient's K-RAS mutation status, in order to support sales of Vectibix®, Amgen's colorectal cancer therapy.
Dr Stephen Little, CEO of DxS said: "The achievement of ISO 13485 certification underlines our commitment to provide the highest standards in our products and services, and demonstrates our ability to consistently meet customer and regulatory requirements."
QIAGEN announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays. Research has shown that variation in the PI3K gene could be a key biomarker for use as a co ... more
QIAGEN N.V. announced that it has acquired DxS Ltd (DxS), a privately-held developer and manufacturer of companion diagnostic products headquartered in Manchester, United Kingdom. The transaction is valued at approximately US$ 95 million in cash (subject to customary purchase price adjustm ... more
DxS Ltd has announced the appointment of Jeff Devlin as Chief Operating Officer.
Prior to DxS, Jeff held positions as Executive VP and Executive Committee member of Shire Pharmaceuticals, where he played a key role in strategy and integration. Before this he was a Partner in Ernst and You ... more